Biogen (BIIB) Change in Inventory (2009 - 2026)

Biogen has reported Change in Inventory for 18 years, with the latest figure at -$75.7 million in Q2 2026.

• On a quarterly basis, Change in Inventory fell 184.2% year-over-year to -$75.7 million in Q2 2026; TTM through Jun 2026 was -$155.1 million, a 236.65% decrease from a year earlier, with the FY2025 full-year figure at $64.7 million, down 76.37% from the prior year.
• Change in Inventory was -$75.7 million for Q2 2026 at Biogen, up from -$116.2 million in the prior quarter.
• The five-year high for Change in Inventory was $142.6 million in Q1 2022, with the low at -$116.2 million in Q1 2026.
• Average Change in Inventory over 5 years is $33.2 million, with a median of $47.9 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Change in Inventory surged 630.39% in 2023, then sank 184.2% in 2026.
• Over 5 years, Change in Inventory stood at -$18.1 million in 2022, then soared by 630.39% to $96.0 million in 2023, then sank by 30.83% to $66.4 million in 2024, then plunged by 55.72% to $29.4 million in 2025, then slumped by 357.48% to -$75.7 million in 2026.
• The last three Change in Inventory figures came in at -$75.7 million (Q2 2026), -$116.2 million (Q1 2026), and $29.4 million (Q4 2025), per Business Quant data.